These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38300604)

  • 1. Patterns of publicly funded naltrexone use among patients diagnosed with alcohol use disorder in Ontario.
    Tourchian N; McCormack D; Leece P; Tadrous M; Gomes T
    Alcohol Alcohol; 2024 Jan; 59(2):. PubMed ID: 38300604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario.
    Spithoff S; Turner S; Gomes T; Martins D; Singh S
    Can Fam Physician; 2017 May; 63(5):e277-e283. PubMed ID: 28500210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.
    Muvvala SB; O'Malley SS; Rosenheck R
    Am J Addict; 2021 Jan; 30(1):55-64. PubMed ID: 32805083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada.
    Konstantelos N; Tourchian N; McCormack D; Lecce P; Tadrous M; Gomes T
    Drug Alcohol Depend; 2023 Jan; 242():109705. PubMed ID: 36463765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
    Xu KY; Presnall N; Mintz CM; Borodovsky JT; Bhat NR; Bierut LJ; Grucza RA
    JAMA Netw Open; 2021 Feb; 4(2):e210061. PubMed ID: 33625511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider perspectives on emergency department initiation of medication assisted treatment for alcohol use disorder.
    Philippine T; Forsgren E; DeWitt C; Carter I; McCollough M; Taira BR
    BMC Health Serv Res; 2022 Apr; 22(1):456. PubMed ID: 35392901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities.
    Qeadan F; Mensah NA; Gu LY; Madden EF; Venner KL; English K
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of prescription orders for United States active duty service members diagnosed with alcohol use disorder.
    Peters ZJ; Kincaid MW; Greenberg JG; Quah RF; Curry JC
    Subst Abus; 2021; 42(4):638-645. PubMed ID: 32870103
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.
    Oldfield BJ; McGinnis KA; Edelman EJ; Williams EC; Gordon AJ; Akgün K; Crystal S; Fiellin LE; Gaither JR; Goulet JL; Korthuis PT; Marshall BDL; Justice AC; Bryant K; Fiellin DA; Kraemer KL
    J Subst Abuse Treat; 2020 Feb; 109():14-22. PubMed ID: 31856946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.
    Vannier AGL; Shay JES; Fomin V; Patel SJ; Schaefer E; Goodman RP; Luther J
    JAMA Netw Open; 2022 May; 5(5):e2213014. PubMed ID: 35594048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baclofen for alcohol use disorder.
    Agabio R; Saulle R; Rösner S; Minozzi S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012557. PubMed ID: 36637087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders.
    Mintz CM; Presnall NJ; Xu KY; Hartz SM; Sahrmann JM; Bierut LJ; Grucza RA
    Drug Alcohol Depend; 2021 Sep; 226():108886. PubMed ID: 34245997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol Use Disorder Treatment in Sexually and Gender Diverse Patients: A Retrospective Cohort Study.
    McDowell MJ; King DS; Gitin S; Miller AS; Batchelder AW; Busch AB; Greenfield SF; Huskamp HA; Keuroghlian AS
    J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37656181
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.
    Korthuis PT; Lum PJ; Vergara-Rodriguez P; Ahamad K; Wood E; Kunkel LE; Oden NL; Lindblad R; Sorensen JL; Arenas V; Ha D; Mandler RN; McCarty D;
    Addiction; 2017 Jun; 112(6):1036-1044. PubMed ID: 28061017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review.
    Hyland CJ; McDowell MJ; Bain PA; Huskamp HA; Busch AB
    J Subst Abuse Treat; 2023 Jan; 144():108919. PubMed ID: 36332528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
    Abraham AJ; Knudsen HK; Roman PM
    J Stud Alcohol Drugs; 2011 Jul; 72(4):669-77. PubMed ID: 21683049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.
    Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization.
    Kranzler HR; Stephenson JJ; Montejano L; Wang S; Gastfriend DR
    Addiction; 2008 Nov; 103(11):1801-8. PubMed ID: 19032530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predischarge Injectable Versus Oral Naltrexone to Improve Postdischarge Treatment Engagement Among Hospitalized Veterans with Alcohol Use Disorder: A Randomized Pilot Proof-of-Concept Study.
    Busch AC; Denduluri M; Glass J; Hetzel S; Gugnani SP; Gassman M; Krahn D; Deyo B; Brown R
    Alcohol Clin Exp Res; 2017 Jul; 41(7):1352-1360. PubMed ID: 28605827
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.